Iron Therapy in ESRD Patients with Sepsis

Clinical Approach During Active Sepsis

• The Surviving Sepsis Campaign guidelines recommend focusing on hemodynamic resuscitation and source control first, particularly for patients with severe anemia (hemoglobin <7.0 g/dL) who may require RBC transfusion for immediate correction 1, 2, 3
• For severe anemia during active sepsis, RBC transfusion is considered a better option than iron therapy for immediate correction, especially in cases of tissue hypoperfusion, myocardial ischemia, or severe hypoxemia 1, 2, 3

Iron Status Assessment

• The Kidney International journal suggests evaluating iron parameters (ferritin, transferrin saturation) once the patient is stabilized, as these markers can be falsely elevated during acute inflammation and infection 4
• Ferritin acts as an acute phase reactant and may be elevated during sepsis independent of true iron stores, according to the Kidney International journal 4

Post-Sepsis Iron Replacement Strategy

• The KDIGO guidelines recommend IV iron trials for CKD patients when TSAT ≤30% and ferritin ≤500 ng/mL to increase hemoglobin or decrease ESA dose, as stated in the Kidney International journal 4
• For ESRD patients on hemodialysis with documented iron deficiency (TSAT ≤30% and ferritin ≤500 ng/mL), intravenous iron is indicated to support erythropoiesis and reduce ESA requirements, according to the Kidney International journal 4

Important Safety Considerations

• Iron overload from excessive cumulative IV iron doses may increase cardiovascular events and mortality in dialysis patients, as reported in the Drugs journal 6
• The benefits of correcting iron deficiency (improved hemoglobin, reduced ESA requirements, decreased transfusion needs) should be balanced against potential harms on an individual basis, according to the Kidney International journal 4

Route and Monitoring

• Administer IV iron only with staff trained to manage anaphylactic reactions, and observe patients for at least 30 minutes post-infusion due to risk of anaphylactoid reactions, as recommended by the Kidney International journal and other sources, but not exclusively from Praxis Medical Insights 5